Drug Shortage Report for ACT LEVOFLOXACIN
Report ID | 221531 |
Drug Identification Number | 02315440 |
Brand name | ACT LEVOFLOXACIN |
Common or Proper name | LEVOFLOXACIN 750MG FC TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | LEVOFLOXACIN |
Strength(s) | 750MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 50 |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-03-06 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-03-07 | French | Compare |
v1 | 2024-03-07 | English | Compare |
Showing 1 to 2 of 2